chlorhexidine gluconate and isopropyl alcohol
CHLORAPREP ONE-STEP FREPP (chlorhexidine gluconate and isopropyl alcohol) by Becton Dickinson. Approved for bacteria. First approved in 2000.
Drug data last refreshed 20h ago · AI intelligence enriched 2w ago
CHLORAPREP ONE-STEP FREPP is a topical antimicrobial sponge combining chlorhexidine gluconate and isopropyl alcohol, indicated for bacterial skin antisepsis prior to surgical and medical procedures. The formulation works by disrupting bacterial cell membranes and denaturing proteins, providing rapid and sustained antimicrobial activity.
Product is within 1 year of loss of exclusivity; commercial teams are likely focused on competitive defense and portfolio transition strategies.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Worked on CHLORAPREP ONE-STEP FREPP at Becton Dickinson? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Patent cliff in less than a year — expect lifecycle management and generic defense hiring
Working on CHLORAPREP ONE-STEP FREPP offers exposure to operational and commercial execution in a mature, commodity-like product category with high manufacturing and supply chain relevance. Career trajectory is best suited for supply-side professionals (manufacturing, engineering, QA) or those seeking commercial experience in contract management and channel optimization rather than market expansion.
456 open roles linked to this drug
Upgrade to Pro to access patent cliff timelines and LOE dates and other premium pharma intelligence.
Upgrade to Pro — $25/mo